Baqsimi

Gastrointestinal tract structure, Hypoglycemia, Type 2 Diabetes + 1 more

Treatment

2 FDA approvals

20 Active Studies for Baqsimi

Treatment for

Gastrointestinal tract structure

What is Baqsimi

GlucagonThe Generic name of this drug

Treatment SummaryGlucagon is a hormone made up of 29 amino acids that is used to slow down the movement of food through the digestive system or to raise low blood sugar levels. It works by activating receptors in the liver, which then triggers the breakdown of glycogen and the release of glucose into the bloodstream. It was approved by the FDA in 1960 and is used as a diagnostic aid in certain radiological exams.

Glucagonis the brand name

image of different drug pills on a surface

Baqsimi Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Glucagon

1999

Approved as Treatment by the FDA

Glucagon, otherwise called Glucagon, is approved by the FDA for 2 uses including Gastrointestinal tract structure and Hypoglycemia .

Gastrointestinal tract structure

Hypoglycemia

Effectiveness

How Baqsimi Affects PatientsGlucagon is used as a test to slow down the movement of the digestive system and to treat dangerously low blood sugar levels. It works by activating certain receptors in the liver, which causes the body to release glucose and raise blood sugar. The effects of glucagon are short-lived, but can lead to high blood sugar levels in diabetic patients.

How Baqsimi works in the bodyGlucagon binds to its receptor and triggers a chain reaction in the body. Adenylate cyclase is activated, which increases the amount of cyclic AMP. Protein kinase A is also activated, which breaks down glycogen. Glucagon also relaxes the muscles of the stomach, duodenum, small bowel and colon.

When to interrupt dosage

The recommended dosage of Baqsimi depends on the determined condition, such as Gastrointestinal tract structure, Type 2 Diabetes and Type 2 Diabetes. The dose varies in accordance with the mode of delivery (e.g. Intramuscular; Intravenous; Subcutaneous or Injection, powder, for solution - Intramuscular; Intravenous; Subcutaneous) specified in the table below.

Condition

Dosage

Administration

Hypoglycemia

, 1.0 mg/mL, 1.0 mg, 3.0 mg, 5.0 mg/mL, 10.0 mg/mL, 0.5 mg

, Kit, Intramuscular; Intravenous; Subcutaneous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous; Subcutaneous, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous; Subcutaneous, Powder, for solution - Intramuscular; Intravenous; Subcutaneous, Powder, for solution, Intramuscular, Kit; Powder, for solution - Intramuscular, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Kit - Intramuscular; Intravenous; Subcutaneous, Powder - Nasal, Nasal, Powder, Injection, solution, Subcutaneous, Injection, solution - Subcutaneous, Kit - Intramuscular; Intravenous

Type 2 Diabetes

, 1.0 mg/mL, 1.0 mg, 3.0 mg, 5.0 mg/mL, 10.0 mg/mL, 0.5 mg

Gastrointestinal tract structure

, 1.0 mg/mL, 1.0 mg, 3.0 mg, 5.0 mg/mL, 10.0 mg/mL, 0.5 mg

Type 2 Diabetes

, 1.0 mg/mL, 1.0 mg, 3.0 mg, 5.0 mg/mL, 10.0 mg/mL, 0.5 mg

Warnings

Baqsimi Contraindications

Condition

Risk Level

Notes

Glucagonoma

Do Not Combine

Insulinoma

Do Not Combine

Pheochromocytomas

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Glucagon may interact with Pulse Frequency

There are 20 known major drug interactions with Baqsimi.

Common Baqsimi Drug Interactions

Drug Name

Risk Level

Description

(R)-warfarin

Minor

The therapeutic efficacy of (R)-warfarin can be increased when used in combination with Glucagon.

(S)-Warfarin

Minor

The therapeutic efficacy of (S)-Warfarin can be increased when used in combination with Glucagon.

4-hydroxycoumarin

Minor

The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Glucagon.

Acenocoumarol

Minor

The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Glucagon.

Clorindione

Minor

The therapeutic efficacy of Clorindione can be increased when used in combination with Glucagon.

Baqsimi Toxicity & Overdose RiskSymptoms of glucagon overdose include nausea, vomiting, slowed digestion, high blood pressure and heart rate, and low levels of potassium in the blood. Blood pressure can be brought under control through the administration of phentolamine. Treatment of overdose is mainly focused on treating the nausea, vomiting, and low potassium levels. The toxic dose for glucagon has been found to be 300mg/kg in mice and 38.6mg/kg in rats.

image of a doctor in a lab doing drug, clinical research

Baqsimi Novel Uses: Which Conditions Have a Clinical Trial Featuring Baqsimi?

248 active clinical trials are being conducted to examine the potential of Baqsimi for alleviating Type 2 Diabetes, Hypoglycemia and Type 2 Diabetes Mellitus.

Condition

Clinical Trials

Trial Phases

Type 2 Diabetes

92 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Phase 3, Phase 4

Type 2 Diabetes

193 Actively Recruiting

Phase 2, Not Applicable, Early Phase 1, Phase 1, Phase 4, Phase 3

Hypoglycemia

0 Actively Recruiting

Gastrointestinal tract structure

0 Actively Recruiting

Baqsimi Reviews: What are patients saying about Baqsimi?

3.3Patient Review

8/2/2020

Baqsimi for Low Blood Sugar

On the plus side, this treatment is effective. On the downside, I had a really terrible experience that has left me with PTSD.

3Patient Review

3/9/2020

Baqsimi for Low Blood Sugar

The FDA needs to rethink its decision to allow this drug on the market. It's incredibly painful, and doesn't actually seem to do anything to help with my sinuses.

2Patient Review

5/4/2021

Baqsimi for Low Blood Sugar

I felt a lot of pain while taking this medication.

1.7Patient Review

6/27/2021

Baqsimi for Low Blood Sugar

Violent, unpleasant experience that led to me spending twelve hours in the ER. Do not try this drug!

1.3Patient Review

4/16/2022

Baqsimi for Low Blood Sugar

I used this for low blood sugar and now my eye is burning and my head hurts. I would not recommend this to anyone.

1Patient Review

10/1/2021

Baqsimi for person with diabetes mellitus at risk of hypoglycemia

This medication is incredibly harsh and unpleasant. After using it, I felt like I had been pepper sprayed. My eyes and face were on fire, and I ended up with a migraine so bad that I vomited.

image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about baqsimi

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

When should I take BAQSIMI?

"If your blood sugar falls from a low level to a very low level, you may have very low blood sugar and need BAQSIMI. BAQSIMI should be used in an emergency situation where you cannot eat or drink and need assistance from someone else."

Answered by AI

What is BAQSIMI used for?

"BAQSIMI is a dry nasal spray used to treat very low blood sugar in people with diabetes. It is the first and only treatment of its kind."

Answered by AI

How much does BAQSIMI raise blood sugar?

"In clinical studies, Baqsimi has been shown to raise blood sugar back to normal levels in 98.8% to 100% of adults within 11.6 to 15.9 minutes."

Answered by AI

Is glucagon the same as BAQSIMI?

"The active ingredient in BAQSIMI, glucagon, has been in use for many years. In a clinical study, BAQSIMI was shown to be just as effective as glucagon injections in raising blood sugar levels in adults. BAQSIMI is available in a single dose form, which is the same for people aged 4 and up."

Answered by AI